CARL WAYNE STEELE

Allopathic & Osteopathic Physicians|Family Medicine PORT CLINTON, OH NPI 1457469751

General Payments — all program years on this page

$1,770.06

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 116
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $300.50 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $300.5016

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $139.028
ABBVIE INC. $52.252
Novo Nordisk AS $38.632
Corcept Therapeutics $36.722
Lilly USA, LLC $19.441
PFIZER INC. $14.441

By program year

Program yearAmountRecords
2018 $375.2531
2019 $314.9521
2020 $151.0011
2021 $213.1313
2022 $200.4012
2023 $214.8312
2024 $300.5016

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096771148 Novo Nordisk Inc $16.59 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097628665 Novo Nordisk Inc $22.04 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104234307 AstraZeneca Pharmaceuticals LP $17.22 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104268489 AstraZeneca Pharmaceuticals LP $16.83 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104402299 AstraZeneca Pharmaceuticals LP $13.35 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104440717 AstraZeneca Pharmaceuticals LP $25.17 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104448223 AstraZeneca Pharmaceuticals LP $15.45 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104618906 AstraZeneca Pharmaceuticals LP $20.92 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104778804 AstraZeneca Pharmaceuticals LP $20.57 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105443672 AstraZeneca Pharmaceuticals LP $9.51 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106156299 ABBVIE INC. $22.43 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106156302 ABBVIE INC. $29.82 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117756995 Corcept Therapeutics $16.18 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117757063 Corcept Therapeutics $20.54 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131190544 PFIZER INC. $14.44 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136091356 Lilly USA, LLC $19.44 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.